Arterial Blood Supply of Hepatocellular Carcinoma and Histologic Grading: Radiologic Pathologic Correlation

Size: px
Start display at page:

Download "Arterial Blood Supply of Hepatocellular Carcinoma and Histologic Grading: Radiologic Pathologic Correlation"

Transcription

1 sayama et al. rterial lood Supply of HCC and Histologic Grading Hepatobiliary Imaging Original Research Yoshiki sayama 1,2 Kengo Yoshimitsu 1 Yunosuke Nishihara 3 Hiroyuki Irie 1 Shinichi ishima 3 kinobu Taketomi 4 Hiroshi Honda 1 sayama Y, Yoshimitsu K, Nishihara Y, et al. Keywords: CT, hemodynamics, hepatocellular carcinoma, liver disease, proliferative activity, unpaired artery, vascular imaging DOI: /JR Received February 23, 2007; accepted after revision ugust 7, Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan. 2 Present address: Department of Radiology, University of Iowa Hospitals and Clinics, 200 Hawkins Dr., Iowa City, I ddress correspondence to Y. sayama. 3 Department of natomic Pathology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan. 4 Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan. WE This is a Web exclusive article. JR 2008; 190:W28 W X/08/1901 W28 merican Roentgen Ray Society rterial lood Supply of Hepatocellular Carcinoma and Histologic Grading: Radiologic Pathologic Correlation OJECTIVE. The objective of our study was to clarify the sequential changes of arterial blood supply during the development of hepatocellular carcinoma (HCC) with an emphasis on its late stage. MTERILS ND METHODS. Sixty HCC nodules were confirmed at pathology in 59 patients who had undergone CT hepatic arteriography and CT during arterioportography (CTP). Lesions were classified into one of the four groups: group 1, nodules that appeared to show preserved portal perfusion on CTP and showed hypo- or isoattenuation on CT hepatic arteriography; group 2, very hyperattenuating on CT hepatic arteriography; group 3, hyperattenuating on CT hepatic arteriography; and group 4, hypo- or isoattenuating on CT hepatic arteriography. s 2, 3, and 4 showed the portal perfusion defect on CTP. These hemodynamic patterns were compared among different histologic grades. We also examined the number of unpaired arteries and the Ki-67 labeling index of the tumor pathologically. RESULTS. The numbers of lesions in each group were as follows for groups 1, 2, 3, and 4, respectively: 17, one, two, and 0 well-differentiated HCCs; 0, 10, nine, and one moderately differentiated HCC; and 0, three, 12, and five poorly differentiated HCCs. The lesions showed significantly different hemodynamic patterns among different histologic grades (Cramer s V = , p < ). The number of unpaired arteries showed a strong correlation with Ki- 67 labeling index in well-differentiated HCC and moderately differentiated HCC (rho = 0.673, p < ) and a moderate inverse correlation with Ki-67 labeling index in poorly differentiated HCC (rho = 0.540, p = ). CONCLUSION. In the late stage of HCC development, the arterial blood supply significantly decreases as the histologic grade progresses. epatocellular carcinoma (HCC) is H one of the most common malignancies in many parts of the world [1]. Recent advances in imaging have enabled researchers to evaluate the hemodynamics of a hepatocellular lesion in particular, dysplastic nodules or early HCCs using CT hepatic arteriography and CT during arterial portography (CTP) [2]. During hepatocarcinogenesis, most hepatocellular nodules show a deterioration of arterial blood flow before the loss of portal blood flow. Subsequently, as a result of a marked increase in neovascularized arteries, arterial blood flow becomes dominant. The portal blood flow decreases with the advancement of tumor, and the tumor is eventually fed mainly by arterial flow [3]. The changes of intranodular blood supply in a regenerative nodule, dysplastic nodule, and well-differentiated HCC have been well described [2 4]. dvanced HCC usually indicates moderately differentiated HCC or poorly differentiated HCC, and these two have been studied inseparably in the radiology literature until now [3, 4]. The hemodynamic changes in moderately differentiated HCC and poorly differentiated HCC have not been well evaluated radiologically or pathologically in a previous study, to our knowledge. The survival of patients with poorly differentiated HCC, however, is reportedly worse than that of those with moderately differentiated HCC in surgically resected cases [5]. In particular, Jonas et al. [6] revealed that the survival of patients with poorly differentiated HCC was significantly worse than survival of patients with well- and moderately differentiated HCC after liver transplantation. Therefore, it would be of clinical benefit if these two groups could be differentiated clinically or radiologically. We have previously reported W28 JR:190, January 2008

2 rterial lood Supply of HCC and Histologic Grading that some poorly differentiated HCCs showed a decreased arterial blood supply [7]. In terms of hepatocarcinogenesis, the number of unpaired arteries is substantially greater in HCCs than in cirrhotic nodules or dysplastic nodules and tends to correlate with the degree of arterial contrast enhancement [2, 3, 8]. The most widely used proliferation-associated marker is Ki-67. Ki-67 is a nuclear antigen present only in proliferating cells. detailed cell cycle analysis showed that the Ki-67 antigen is expressed in cells during the G 1, S, and G 1 M phases but not during the G 0 phase of the cell cycle [9, 10]. The diagnostic and prognostic value of Ki-67 immunostaining of human tumors has been well documented [11]. In HCC, Ki-67 expression was found to correlate closely with tumor growth rate [12] and was an independent prognostic indicator of patient disease-free and overall survival rates [13]. In this study, we hypothesized that arterial flow might, in general, decrease in the late stage of HCC development (moderately differentiated HCC to poorly differentiated HCC), whereas it increases in the early stage (welldifferentiated HCC to moderately differentiated HCC), as previously described [2 4]. The purpose of this study was to evaluate the hemodynamic patterns of HCCs on CT hepatic arteriography and CTP during the development of HCC, with a particular emphasis on its late stage, in correlation with the number of unpaired arteries and the expression of Ki-67 (proliferative activity index). Materials and Methods There were 199 consecutive HCC patients (212 nodules) who underwent surgical resection at our hospital from March 2003 to February Of these 199 patients, 26 patients (27 nodules) were excluded because they underwent preoperative radiofrequency ablation or transarterial chemotherapy. Of 173 patients (185 nodules), 136 patients (144 nodules) underwent CTP and CT hepatic arteriography preoperatively. Of these 144 nodules, 20, 92, and 32 nodules were proven to be well-differentiated HCC, moderately differentiated HCC, and poorly differentiated HCC, respectively, on the basis of the definitions provided by the Japanese Liver Cancer [14]. We randomly chose 20 of the 92 moderately differentiated HCCs and 20 of the 32 poorly differentiated HCCs. Finally, a total of 60 cases (20 well-differentiated HCCs, 20 moderately differentiated HCCs, and 20 poorly differentiated HCCs) comprised the study population. Tumor size was not taken into consideration for inclusion criteria. The mean size (± SD) of the well-differentiated HCCs, moderately differentiated HCCs, and poorly differentiated HCCs was 1.8 ± 0.6, 2.6 ± 1.5, and 4.2 ± 2.9 cm, respectively. The mean time interval between imaging (i.e., CT hepatic arteriography and CTP) and surgical resection was 14.2 ± 4.2 days. Our institutional review board does not require its approval or informed consent for the retrospective evaluation of patients records and images. CT Protocols CT hepatic arteriography and CTP were performed using a 4-MDCT unit (quilion, Toshiba) immediately after unenhanced scanning of the liver. The parameters for scanning were as follows: collimation, 3 mm; reconstruction, 5 mm; pitch, 5.5: amperage, 300 ms; kilovoltage, 120 kvp; and table speed, 16.5 mm per rotation. For CTP, data acquisition was started 30 seconds after the initiation of a transcatheter arterial injection of 100 ml of nonionic contrast material (iopamidol, 150 mg I/mL [Iopamiron 150, ayer HealthCare]) at 2.5 ml/s using an automated power injector. efore the contrast material was injected, a transarterial infusion of prostaglandin E 1 (10 mg) as a vasodilator was performed. Data acquisition of CT hepatic arteriography began 15 (first phase) and 30 (second phase) seconds after the initiation of a transcatheter hepatic arterial injection of ml of nonionic contrast material at a rate of ml/s using an automated power injector. The appropriate injection rate for CT hepatic arteriography was determined to be the maximum injection rate, which basically depended on the vessel caliber, that would not cause backward flow of contrast material on hepatic arteriography. The duration of the arterial injection was 20 seconds. Pathologic Evaluation For all 60 nodules, two experienced pathologists with 2 and 7 years of experience with liver pathology examined the resected specimens with no knowledge of the preoperative CT findings in a consensus fashion. Unpaired arteries in neoangiogenesis were not associated with the portal tract, fibrous tissue, septa, or other units (e.g., bile duct). The unpaired arteries were assessed according to established methods of vascular counting as follows [15]: the three neovascularized areas (hot spots) were originally identified at low magnification ( 40) and were circled in pen, then the absolute number of unpaired arteries was counted in a single field at the highest magnification ( 200) within every hot spot area. Immunohistochemistry Ki-67 was detected immunohistochemically by the streptavidin-biotin peroxidase method [16] using anti-ki-67 (MI-1, DakoCytomation). To measure the Ki-67 labeling index, more than 1,000 cells were counted in randomly selected high-power fields, and the number of Ki-67 positive nuclei was recorded in each field. The labeling index was defined as the ratio of Ki-67 labeled cells to the total number of cells counted and was expressed as percentages. ssessment Images of the largest axial sections of the tumor were evaluated by two radiologists with 11 and 19 years of experience with CT of the liver in a consensus fashion. ll interpretations were independently made from the axial CT images on a monitor (Coronis 3MP, arco), and the observers were completely blinded to the pathologic and clinical findings for each case. On the monitor, images obtained with routine window settings (window level, 100 H; window width, 500 H) were viewed. ll lesions were classified in one of the following groups on the basis of the enhancement patterns observed on CT hepatic arteriography and CTP: group 1, nodules that showed preserved portal perfusion on CTP and were hypo- or isoattenuating on CT hepatic arteriography (Fig. 1); group 2, portal perfusion defect on CTP and nodules were very hyperattenuating compared with noncancerous liver on CT hepatic arteriography (Fig. 2); group 3, portal perfusion defect on CTP and nodules were hyperattenuating compared with noncancerous liver on CT hepatic arteriography (Fig. 3); and group 4, portal perfusion defect on CTP and nodules were hypo- or isoattenuating compared with noncancerous liver on CT hepatic arteriography (Fig. 4). On CTP, preserved portal perfusion is defined as isoattenuation or decreased perfusion that is still partially preserved compared with noncancerous areas. s for the difference between groups 2 and 3, the lesions seen on CT hepatic arteriography in group 3 showed a hazy increase in the tumor attenuation level that is not associated with obscuration of the intratumoral vascular structure. In contrast, if a tumor showed obscuration of the vascular structure, the lesion was classified in group 2. In the case of a tumor showing various attenuation levels, the majority attenuation level was noted. ecause the intratumoral hypoattenuation area that exhibited no contrast enhancement in all phases was considered to be tumor necrosis, we excluded those areas from evaluation. We compared the attenuation pattern and the Ki-67 labeling index. We also compared the number of unpaired arteries and the Ki-67 labeling index. Statistical nalysis Continuous variables were expressed as means ± SD and tested using the Student s t test. The level of significance was set at a p value of less than 0.05 for all tests. Cramer s V with chi-square was used for radiologic pattern and tumor differentiation. The value of the level of association was interpreted as follows: JR:190, January 2008 W29

3 sayama et al. Fig year-old man with moderately differentiated hepatocellular carcinoma (group 1) in right lobe of liver. seconds after contrast material injection shows hypoattenuating mass (arrow) compared with noncancerous region. isoattenuating mass compared with noncancerous region. Number of unpaired arteries is one, and Ki-67 labeling index is 9. Fig year-old man with moderately differentiated hepatocellular carcinoma (group 2) in right lobe of liver. seconds after contrast material injection shows very hyperattenuating mass (arrow) compared with noncancerous region. perfusion defect compared with noncancerous region. Number of unpaired arteries is 13, and Ki-67 labeling index is 25. Fig year-old man with poorly differentiated hepatocellular carcinoma (group 3) in right lobe of liver. seconds after contrast material injection shows hazy hyperattenuating mass (arrows) compared with noncancerous region. perfusion defect compared with noncancerous region. Number of unpaired arteries is nine, and Ki-67 labeling index is , no relationship; , not generally useful; , weak; > , moderate; > , moderately strong; > , strong; > , very strong; > , worrisomely strong; > , redundant; and 1.00, perfect relationship. Spearman s rank correlation coefficient test was used to determine the correlation between the number of unpaired arteries and the Ki-67 labeling index. correlation coefficient value of up to 0.20 showed virtually no correlation; , weak correlation; , moderate correlation; , high correlation; and 0.81 or greater, very high correlation. W30 JR:190, January 2008

4 rterial lood Supply of HCC and Histologic Grading TLE 1: Radiographic Pattern and Pathologic Findings Results Details of the radiographic pattern and pathologic findings are shown in Table 1. The number of cases in groups 1, 2, 3, and 4 were 17 (all were well-differentiated HCCs), 14 (one well-differentiated HCC, 10 moderately differentiated HCCs, and three poorly differentiated HCCs), 23 (two well-differentiated HCCs, nine moderately differentiated HCCs, and 12 poorly differentiated HCCs), and six (one moderately differentiated HCC and five poorly differentiated HCCs), respectively (Cramer s V = , p < ). In hypervascular HCC (groups 2 and 3), three of 14 C Fig year-old man with poorly differentiated hepatocellular carcinoma (group 4) in right lobe of liver. seconds after contrast material injection from right hepatic artery shows hypoattenuating mass (arrows) compared with noncancerous region (arrowheads). perfusion defect (arrowheads) compared with noncancerous region. Number of unpaired arteries is three, and Ki-67 labeling index is 178. C, Immunohistochemical staining of Ki-67. Nuclei of tumor cells were diffusely positive for Ki-67 staining. Radiologic Pattern Well-Differentiated HCC Moderately Differentiated HCC Poorly Differentitated HCC Characteristic No. of cases Pathologic findings No. of unpaired arteries 2.1 ± ± ± ± ± ± ± 3.3 Ki-67 labeling index 0.7 ± ± ± ± ± ± ± 15.6 Note Dash ( ) indicates not applicable. Data are presented as mean ± SD or as value if there was only case. HCC = hepatocellular carcinoma. cases (21.4%) in group 2 were poorly differentiated HCCs, and 12 of 23 cases (52.2%) in group 3 were poorly differentiated HCCs. In group 4, five of six cases (83.3%) were poorly differentiated HCCs. The mean number of unpaired arteries in moderately differentiated HCC (10.5 ± 4.1) was significantly higher JR:190, January 2008 W31

5 rterial lood Supply of HCC and Histologic Grading Fig. 5 Relationship between CT during arterioportography and CT hepatic arteriography findings and Ki-67 labeling index. Note that Ki-67 labeling index of group 4 was significantly higher than those of other groups. Ki-67 Labeling Index p = p = p = p = p = p = than that in poorly differentiated HCC (4.7 ± 3.9, p < ) and in well-differentiated HCC (2.5 ± 1.5, p < ). The mean number of unpaired arteries in poorly differentiated HCC was significantly higher than that in well-differentiated HCC (p = ). In well-differentiated HCC, the highest Ki- 67 labeling index was observed in group 2 (3.0), followed by group 3 (2.6 ± 3.5) and group 1 (0.7 ± 0.6). In moderately differentiated HCC, the highest Ki-67 labeling index was observed in group 2 (10.6 ± 9.0), followed by group 4 (6.9) and group 3 (6.6 ± 6.7). In contrast, in poorly differentiated HCC, the highest Ki-67 labeling index was observed in group 4 (40.7 ± 15.6), followed by group 3 (26.1 ± 17.1) and group 2 (9.1 ± 7.8). The number of unpaired arteries showed a strong correlation with Ki-67 labeling index in welldifferentiated HCC and moderately differentiated HCC (rho = 0.673, p < ). In contrast, the number of unpaired arteries showed a moderate inverse correlation with Ki-67 labeling index in poorly differentiated HCC (rho = 0.540, p = ). The relationship between the radiologic findings and the Ki-67 labeling index of all HCCs is shown in Figure 5. The Ki-67 labeling indexes of group 2 (9.8 ± 8.3), group 3 (16.4 ± 16.4), and group 4 (35.1 ± 19.6) were higher than that of group 1 (7.1 ± 5.5) (p = , p = , and p < , respectively). The Ki-67 labeling index of group 4 was higher than those of group 2 and group 3 (p = and , respectively). The Ki-67 labeling index of group 3 tended to be higher than that of group 2, but the difference was not significant (p = 0.167). Discussion Investigators have reported a correlation between the blood supply and the grade of malignancy of hepatocellular nodules in radiologic and pathologic analyses [2 4]. In these articles, researchers focused on precancerous lesion and early-stage HCCs namely, low-grade and high-grade dysplastic nodules and well-differentiated HCC. However, few previous reports have discussed the vascular changes that occur in the late stage of advancement and the direct relationship between the arterial blood flow of the tumor and the tumor s proliferative activity. We have not been able to forecast the proliferative activity of the advanced HCC solely on the basis of radiologic findings. s shown in Table 1, well-differentiated HCCs mainly belonged to group 1, moderately differentiated HCCs mainly belonged to group 2 followed by group 3, and poorly differentiated HCCs mainly belonged to group 3 followed by group 4. The number of unpaired arteries increased as the histologic grade progressed from well-differentiated HCC to moderately differentiated HCC, but it decreased as the tumor grade progressed from moderately differentiated HCC to poorly differentiated HCC. These results suggest that the vascularity of poorly differentiated HCC tends to decrease in comparison with moder- ately differentiated HCC both radiologically and pathologically. In the current study, regarding hypervascular advanced HCC, the Ki-67 labeling index of group 2 (10.6 ± 9.0) was higher than that of group 3 (6.6 ± 6.7) in moderately differentiated HCC, but the Ki-67 labeling index of group 2 (9.1 ± 7.8) was lower than that of group 3 (26.1 ± 17.1) in poorly differentiated HCC (the difference was not significant). Furthermore, the Ki-67 labeling index of group 4 in poorly differentiated HCC was the highest of all the groups. The number of unpaired arteries of well-differentiated HCC and moderately differentiated HCC and of poorly differentiated HCC showed a strong correlation and a moderate inverse correlation with Ki-67 labeling index, respectively. These results also suggest that arterial blood supply increases in the early stage of advancement but that, conversely, it decreases in the late stage of advancement. ccording to this concept, both groups 3 and 4 may theoretically consist of two different subgroups: one with moderate tumor aggressiveness exhibiting an intermediate Ki-67 labeling index and the other with high tumor aggressiveness exhibiting a high Ki-67 labeling index. schematic presentation of this concept regarding the sequential changes of intratumoral arterial blood supply is summarized in Figure 6. The numbers of HCCs belonging to groups 3 and 4 and showing intermediate Ki-67 labeling index (here, it was defined as < 10) that is, those considered to be on the left side of the peak (group 3' and group 4') were 10 (eight moderately differentiated HCCs and two poorly differentiated HCCs) and one (moderately differentiated HCC), respectively. Two cases of well-differentiated HCC also belonged to group 3'. The numbers of HCCs belonging to group 3 and group 4 and showing high Ki-67 labeling index ( 10) that is, those considered to be on the right side of the peak (group 3 and group 4) were 11 (one moderately differentiated HCC and 10 poorly differentiated HCCs) and five (all were poorly differentiated HCCs), respectively. Thus, the HCCs with the group 3' or group 4' hemodynamic pattern and intermediate Ki-67 labeling index were well-differentiated HCC (n = 2) or moderately differentiated HCC (n = 9) (total = 11) rather than poorly differentiated HCC (n =2) and those with the group 3 or group 4 hemodynamic pattern and high Ki-67 labeling index were poorly differentiated HCC (n = 15) rather than moderately differentiated HCC (n =1) (p = , Fisher s exact test). Figure 5 shows that the correlation between the Ki-67 labeling index and the hemodynamic sequence order of groups 1, 2, 3, and JR:190, January 2008 W32

6 rterial lood Supply of HCC and Histologic Grading Neovascularized rterial Flow Ki-67 Labeling Index Equal to noncancerous liver Well- Differentiated HCC Moderately Differentiated HCC dvancement of Pathological Grading 1 1 4' 4' 3' 2 3' Proliferative activity was significant (rho = 0.677, p , Spearman s rank correlation); however, when the sequence was changed to groups 1, 4', 3', 2, 3, and 4, the correlation became stronger (rho = 0.872, p < ) (Fig. 7). This finding may support our hypothetical concept shown in Figure 6. lthough strict differentiation between these two subgroups of group 3 and group 4 namely, group 3' versus group 3 or group 4' versus group 4, in other words, moderately differentiated HCC versus poorly differentiated HCC solely by the presented radiologic method (CT hepatic arteriography and CTP) may be difficult, we believe these imaging techniques can provide important information in an approximate estimation of the proliferative activity of the tumor (Fig. 5). new radiologic approach, such as diffusionweighted imaging or calculated apparent diffusion coefficient values on MRI [17], may be Poorly Differentiated HCC helpful in this strict differentiation of group 3' versus group 3 or of group 4' versus group 4. From the standpoint of implications for patients, Jonas et al. [6] reported that vascular invasion and histopathologic grade of differentiation were identified as the only prognostic parameters in liver transplant recipients. Thus, in planning liver transplantation, evaluation of arterial blood flow can contribute to predict a worse prognosis in patients with hypovascular advanced HCC. Furthermore, transarterial infusion chemotherapy may be not effective for hypovascular advanced HCCs compared with hypervascular HCCs. We should choose alternative treatments as soon as possible because such tumors will show rapid progression due to the high proliferative activity of the tumor cells. In malignant neoplasms, angiogenesis is also required for tumor growth, progression, and metastasis [18 20]. The supply of oxygen Fig. 6 Diagram shows changes of intratumoral arterial blood supply. In welldifferentiated hepatocellular carcinoma (HCC) and moderately differentiated HCC, arterial blood supply increases as histologic grade progresses. Consequently, arterial blood supply decreases in poorly differentiated HCC as tumor grade advances. HCCs belonging to group 3 and group 4 and showing intermediate Ki-67 labeling index (here, it was defined as < 10) that is, those considered to be on left side of peak (group 3' and group 4') mainly consisted of moderately differentiated HCCs. HCCs belonging to group 3 and group 4 and showing high Ki-67 labeling index ( 10) that is, those considered to be on right side of peak (group 3 and group 4) mainly consisted of poorly differentiated HCCs. (Strictly speaking, it seems to be incompatible to place poorly differentiated HCC showing group 3' or group 4' into a portion labeled as well-differentiated HCC or moderately differentiated HCC. However, such tumor is rare.) Moderately differentiated HCC on line shows same degree of arterial blood flow as poorly differentiated HCC on line, but proliferative activity of HCC on line is higher than that of HCC on line. (It is difficult to distinguish from solely by means of CT hepatic arteriography and CT during arterioportography.) Poorly differentiated HCC on line shows hypovascular and very high proliferative activity. It is possible to point out poorly differentiated HCC on line, and thus we can predict proliferative activity of this type of tumor. Fig. 7 Relationship between CT during arterioportography and CT hepatic arteriography findings and Ki-67. In this figure, group 3 was divided into group 3 and group 3', and group 4 was divided into group 4 and group 4'. Correlation between Ki- 67 labeling index and hemodynamic sequence order of group 1, 4', 3', 2, 3, and 4 (rho = 0.872) was stronger than that between Ki-67 labeling index and sequence order of group 1, 2, 3, and 4 (rho = 0.677). and nutrition from the tumor vessels is believed to be essential for the growth of solid tumors [21]. During multistep hepatocarcinogenesis, the arterial blood flow increases from hypovascular well-differentiated HCC to hypervascular classical HCC [2 4]. During this process, the proliferative activity of the tumor cells also increases. In contrast, the Ki-67 labeling index showed a moderate inverse correlation with arterial blood flow in poorly differentiated HCC. Mineura et al. [21] previously reported that high-grade gliomas tended to show lower oxygen consumption than lower-grade gliomas using 15 O PET, and they speculated that high-grade gliomas may have anaerobic metabolism in contrast to the aerobic metabolism of low-grade tumors [21]. Considering our results, a similar mechanism may apply to HCC. Yasuda et al. [22] showed that glycolysis induced by hypoxia JR:190, January 2008 W33

7 sayama et al. inducible factor 1 (HIF-1) is the predominant energy source under the hypoxic environment in metastatic liver cancers, and some clinicians have pretreated HCC by transarterial embolization. It may be presumed that in some poorly differentiated HCCs, tumor cells acquire a metabolic profile of increased glycolysis through the HIF-1 regulated pathway, thus enabling them to proliferate more rapidly under hypoxia. In other words, aerobic metabolizing as the energy source in hypervascular HCC may switch to glycolysis in some poorly differentiated HCCs that show less arterial blood flow. The present study has some limitations. First, there is a possibility that the number of unpaired arteries does not directly reflect the attenuation level of HCC on CT hepatic arteriography. The degree of contrast enhancement of the nodular HCC in the arterial phase tended to correlate with the number of unpaired arteries [8]; however, in our recent study [7], the number of unpaired arteries showed weak correlation with the attenuation level on CT hepatic arteriography and it has been suggested that in addition to arterial blood flow, microvascular permeability is important in the contrast enhancement of a lesion [8, 23]. Second, we did not use a quantitative measure of the tumor on CT hepatic arteriography. However, individual differences in the degree of liver fibrosis can greatly affect the attenuation of the liver tumor and liver parenchyma. This difficulty in evaluating these hepatocellular lesions on the basis of blood supply may add limitations to this study [2]. In conclusion, we showed that arterial blood flow decreased in the late stage of HCC development both radiologically and pathologically. lthough exact differentiation between poorly differentiated HCC and moderately differentiated HCC based on CTP and CT hepatic arteriography is still limited, hypovascular advanced HCC showed higher proliferative activity than hypervascular advanced HCC. cknowledgments We thank Yoshihiko Maehara, Professor and Chair, Department of Surgery and Science, Kyushu University, for providing clinical data and Tsuneyoshi Masazumi, Professor and Chair, Department of natomic Pathology, Kyushu University, for providing pathologic data. We also thank Tsuyoshi Tajima, kihiro Nishie, Masakazu Hirakawa, Kousei Ishigami, and Daisuke Kakihiara, Department of Clinical Radiology, Kyushu University, for editing this manuscript. References 1. Okuda K. Hepatocellular carcinoma: clinicopathological aspects. J Gastroenterol Hepatol 1997; 12: Tajima T, Honda H, Taguchi K, et al. Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. JR 2002; 178: Matsui O. Imaging of multistep human hepatocarcinogenesis by CT during intraarterial contrast injection. Intervirology 2004; 47: Hayashi M, Matsui O, Ueda K, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. JR 1999; 172: Nakajima Y, Shimamura T, Kamiyama T, at al. Evaluation of surgical resection for small hepatocellular carcinomas. m J Surg 1996; 171: Jonas S, echstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: sayama Y, Yoshimitsu K, Irie H, et al. Poorly versus moderately differentiated hepatocellular carcinoma: vascularity assessment by computed tomographic hepatic angiography in correlation with histologically counted number of unpaired arteries. J Comput ssist Tomogr 2007; 31: Kim CK, Lim JH, Park CK, Choi D, Lim HK, Lee WJ. Neoangiogenesis and sinusoidal capillarization in hepatocellular carcinoma: correlation between dynamic CT and density of tumor microvessels. Radiology 2005; 237: Sasaki K, Murakami T, Kawasaki M, Takahashi M. The cell cycle associated change of the Ki-67 reactive nuclear antigen expression. J Cell Physiol 1987; 133: Gerdes J, Dallenbach F, Lennert K, Lemke H, Stein H. Growth fractions in malignant non-hodgkin s lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol 1984; 2: Hall P, Richards M, Gregory WM, d rdenne J, Lister T, Stansfeld G. The prognostic value of Ki67 immunostaining in non-hodgkin s lymphoma. J Pathol 1988; 154: Saito Y, Matsuzaki Y, Doi M, et al. Multiple regression analysis for assessing the growth of small hepatocellular carcinoma: the MI-1 labeling index is the most effective parameter. J Gastroenterol 1998; 33: King KL, Hwang JJ, Chau GY, et al. Ki-67 expression as a prognostic marker in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 1998; 13: Liver Cancer Study of Japan. The general rules for the clinical and pathologic study of primary liver cancer, 4th ed. Tokyo, Japan: Kanehara Publications, ossi P, Viale G, Lee K, lfano R, Coggi G, osari S. ngiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res 1995; 55: Shi ZR, Itzkowitz SH, Kim YS. comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. J Histochem Cytochem 1988; 36: Ichikawa T, Haradome H, Hachiya J, Nitatori T, raki T. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. JR 1998; 170: Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: Liotta L, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324: Mineura K, Yasuda T, Kowada M, Shishido F, Ogawa T, Uemura K. PET evaluation of histologic malignancy in gliomas using 15 O and 18 F-FDG. Neurol Res 1986; 8: Yasuda S, rii S, Mori, et al. Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance. J Hepatol 2004; 40: lmen T. Relations between chemical structure, animal toxicity and clinical adverse effects of contrast media. In: Enge I, Edgren J, eds. Patient safety and adverse events in contrast medium examinations. msterdam, The Netherlands: Elsevier Science, 1989:25 56 W34 JR:190, January 2008

Hepatocellular carcinoma (HCC) is a malignant liver neoplasm

Hepatocellular carcinoma (HCC) is a malignant liver neoplasm Diagn Interv Radiol 2011; 17:328 333 Turkish Society of Radiology 2011 ABDOMINAL IMAGING ORIGINAL ARTICLE Correlation of dynamic multidetector CT findings with pathological grades of hepatocellular carcinoma

More information

Detection and Characterization of Hepatocellular Carcinoma by Imaging

Detection and Characterization of Hepatocellular Carcinoma by Imaging CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:S136 S140 Detection and Characterization of Hepatocellular Carcinoma by Imaging OSAMU MATSUI Department of Imaging Diagnosis and Interventional Radiology,

More information

Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiographyassisted CT) with special reference to multi-step hepatocarcinogenesis

Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiographyassisted CT) with special reference to multi-step hepatocarcinogenesis Abdominal Imaging ª The Author(s) 2011. This article is published with open access at Springerlink.com Published online: 26 January 2011 Abdom Imaging (2011) 36:264 272 DOI: 10.1007/s00261-011-9685-1 INVITED

More information

Early detection and characterization of hepatocellular. Early Detection and Curative Treatment of Early-Stage Hepatocellular Carcinoma

Early detection and characterization of hepatocellular. Early Detection and Curative Treatment of Early-Stage Hepatocellular Carcinoma CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:S144 S148 Early Detection and Curative Treatment of Early-Stage MASATOSHI KUDO Department of Gastroenterology and Hepatology, Kinki University School of

More information

Invited Re vie W. Analytical histopathological diagnosis of small hepatocellular nodules in chronic liver diseases

Invited Re vie W. Analytical histopathological diagnosis of small hepatocellular nodules in chronic liver diseases Histol Histopathol (1 998) 13: 1077-1 087 http://www.ehu.es/histoi-histopathol Histology and Histopathology Invited Re vie W Analytical histopathological diagnosis of small hepatocellular nodules in chronic

More information

CT Evaluation of the Progression of Hypoattenuating Nodular Lesions in Virus-Related Chronic Liver Disease

CT Evaluation of the Progression of Hypoattenuating Nodular Lesions in Virus-Related Chronic Liver Disease Takayasu et al. CT in Liver Disease Hepatobiliary Imaging Original Research A C M E D E N T U R I C A L I M A G I N G Kenichi Takayasu 1 Yukio Muramatsu 2 Yasunori Mizuguchi 1 Takuji Okusaka 3 Kazuaki

More information

Innovations in HCC Imaging: MDCT/MRI

Innovations in HCC Imaging: MDCT/MRI Innovations in HCC Imaging: MDCT/MRI Anthony E. Cheng, M.D. Cardinal MRI Center Cardinal Santos Medical Center, Wilson Street, San Juan Innovations in HCC Imaging: Goals/Objectives MDCT/MRI Learn the diagnostic

More information

HCC and mass effect. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? What you need to know about AFP.

HCC and mass effect. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? What you need to know about AFP. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? Arun J Sanyal M.B.B.S., M.D. Charles Caravati Professor of Medicine Virginia Commonwealth University Imaging features used

More information

Liver Perfusion Analysis New Frontiers in Dynamic Volume Imaging. Case Study Brochure Chang Gung Memorial Hospital.

Liver Perfusion Analysis New Frontiers in Dynamic Volume Imaging. Case Study Brochure Chang Gung Memorial Hospital. New Frontiers in Dynamic Volume Imaging dynamic volume CT Case Study Brochure Chang Gung Memorial Hospital http://www.toshibamedicalsystems.com Toshiba Medical Systems Corporation 2010-2011. All rights

More information

The Diagnosis of Hypovascular Hepatic Lesions Showing Hypo-intensity in the Hepatobiliary Phase of Gd-EOB- DTPA-enhanced MR Imaging in High-risk

The Diagnosis of Hypovascular Hepatic Lesions Showing Hypo-intensity in the Hepatobiliary Phase of Gd-EOB- DTPA-enhanced MR Imaging in High-risk 2013 67 4 239 244 The Diagnosis of Hypovascular Hepatic Lesions Showing Hypo-intensity in the Hepatobiliary Phase of Gd-EOB- DTPA-enhanced MR Imaging in High-risk Patients for Hepatocellular Carcinoma

More information

Index terms: Liver, CT Liver neoplasm, CT. Korean J Radiol 2005;6: Received February 21, 2005; accepted after revision May 24, 2005.

Index terms: Liver, CT Liver neoplasm, CT. Korean J Radiol 2005;6: Received February 21, 2005; accepted after revision May 24, 2005. Depiction of Viable Tumor in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: Multiphasic Helical CT with Review of the Previous Serial CT Images Kyung Mi Jang, MD 1 Dongil Choi,

More information

Focus on Dysplastic Nodules and Early Hepatocellular Carcinoma: An Eastern Point of View. Masamichi Kojiro

Focus on Dysplastic Nodules and Early Hepatocellular Carcinoma: An Eastern Point of View. Masamichi Kojiro Focus on Dysplastic Nodules and Early Hepatocellular Carcinoma: An Eastern Point of View Masamichi Kojiro Although increasing numbers of equivocal nodular lesions have been detected in patients with liver

More information

Liver Tumors. Prof. Dr. Ahmed El - Samongy

Liver Tumors. Prof. Dr. Ahmed El - Samongy Liver Tumors Prof. Dr. Ahmed El - Samongy Objective 1. Identify the most important features of common benign liver tumors 2. Know the risk factors, diagnosis, and management of hepatocellular carcinoma

More information

Visualization of multistep hepatocarcinogenesis using various imaging biomarkers

Visualization of multistep hepatocarcinogenesis using various imaging biomarkers Visualization of multistep hepatocarcinogenesis using various imaging biomarkers Award: Certificate of Merit Poster No.: C-0120 Congress: ECR 2014 Type: Educational Exhibit Authors: S. Kobayashi, T. Gabata,

More information

PEER-REVIEW REPORT CLASSIFICATION LANGUAGE EVALUATION SCIENTIFIC MISCONDUCT CONCLUSION. [ Y] Accept [ ] Grade B: Very good

PEER-REVIEW REPORT CLASSIFICATION LANGUAGE EVALUATION SCIENTIFIC MISCONDUCT CONCLUSION. [ Y] Accept [ ] Grade B: Very good Reviewer s code: 03656588 Reviewer s country: China Date reviewed: 2017-06-08 [ ] Grade A: Excellent [ Y] Accept [ ] Grade B: Very good [ ] High priority for [ Y] Grade C: Good language [ ] Major revision

More information

Intrahepatic Sarcomatoid Cholangiocarcinoma with Portal Vein Thrombosis: A Case Report 1

Intrahepatic Sarcomatoid Cholangiocarcinoma with Portal Vein Thrombosis: A Case Report 1 Intrahepatic Sarcomatoid Cholangiocarcinoma with Portal Vein Thrombosis: A Case Report 1 Jae-Hoon Lim, M.D., Jin Woong Kim, M.D., Suk Hee Heo, M.D., Yong Yeon Jeong, M.D., Heoung Keun Kang, M.D. A 53-year-old

More information

Multiphasic MDCT Enhancement Pattern of Hepatocellular Carcinoma Smaller Than 3 cm in Diameter: Tumor Size and Cellular Differentiation

Multiphasic MDCT Enhancement Pattern of Hepatocellular Carcinoma Smaller Than 3 cm in Diameter: Tumor Size and Cellular Differentiation Gastrointestinal Imaging Original Research Yoon et al. MDCT of Hepatocellular Carcinoma Gastrointestinal Imaging Original Research Soon Ho Yoon 1 Jeong Min Lee 1,2 Young Ho So 1 Sung Hyun Hong 3 Soo Jin

More information

Evangelos Chartampilas Bioclinic Hospital Thessaloniki, Greece

Evangelos Chartampilas Bioclinic Hospital Thessaloniki, Greece Evangelos Chartampilas Bioclinic Hospital Thessaloniki, Greece Hepatospecificcontrast agents Gadobenate dimeglumine (Multihance) Gadoxeticacid (Primovist) 3-5% liver uptake 50% liver uptake Hepatobiliary

More information

Hyperplasia / Hypertrophy, Cirrhosis, Diagnostic procedure, MR, CT-Angiography, CT, Liver, Abdomen /ecr2012/C-2202

Hyperplasia / Hypertrophy, Cirrhosis, Diagnostic procedure, MR, CT-Angiography, CT, Liver, Abdomen /ecr2012/C-2202 Hepatic nodules showing ring-like enhancement on hepatobiliary phase of Gd-EOB-DTPA enhanced MRI can be divided into two subtypes based on blood supply: FNH and NRH-like nodules Poster No.: C-2202 Congress:

More information

Histologic Characteristics of Hepatocellular Carcinomas Showing Atypical Enhancement Patterns on 4-Phase MDCT Examination

Histologic Characteristics of Hepatocellular Carcinomas Showing Atypical Enhancement Patterns on 4-Phase MDCT Examination Original Article http://dx.doi.org/10.3348/kjr.2012.13.5.586 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2012;13(5):586-593 Histologic Characteristics of Hepatocellular Carcinomas Showing Atypical

More information

Vascular and Interventional Radiology Original Research

Vascular and Interventional Radiology Original Research Vascular and Interventional Radiology Original Research Ibukuro et al. Hepatic rtery natomy of the Left Hemiliver Vascular and Interventional Radiology Original Research Kenji Ibukuro 1 Takaya Takeguchi

More information

Review Article Assessment of Stromal Invasion for Correct Histological Diagnosis of Early Hepatocellular Carcinoma

Review Article Assessment of Stromal Invasion for Correct Histological Diagnosis of Early Hepatocellular Carcinoma SAGE-Hindawi Access to Research International Hepatology Volume 2011, Article ID 241652, 7 pages doi:10.4061/2011/241652 Review Article Assessment of Stromal Invasion for Correct Histological Diagnosis

More information

The Egyptian Journal of Hospital Medicine (October 2017) Vol. 69 (4), Page

The Egyptian Journal of Hospital Medicine (October 2017) Vol. 69 (4), Page The Egyptian Journal of Hospital Medicine (October 2017) Vol. 69 (4), Page 2271-2277 Role of Pet/Ct in Assessment of Post Therapeutic Hepatocellular Carcinoma Omar Hussain Omar, Mohamed Elgharib Abo Elmaaty,

More information

Workup of a Solid Liver Lesion

Workup of a Solid Liver Lesion Workup of a Solid Liver Lesion Joseph B. Cofer MD FACS Chief Quality Officer Erlanger Health System Affiliate Professor of Surgery UTHSC-Chattanooga I have no financial or other relationships with any

More information

Embolotherapy for Cholangiocarcinoma: 2016 Update

Embolotherapy for Cholangiocarcinoma: 2016 Update Embolotherapy for Cholangiocarcinoma: 2016 Update Igor Lobko,MD Chief, Division Vascular and Interventional Radiology Long Island Jewish Medical Center GEST 2016 Igor Lobko, M.D. No relevant financial

More information

Financial Disclosure

Financial Disclosure Benign Liver Masses Adil Abdalla, MBBS Creighton University-CHI Health August 25, 2018 Financial Disclosure Nothing to disclose Financial Disclosure 1 Objectives To assess patients with benign liver tumors

More information

Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients

Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients Original Article Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients Wei Wu, Minhua Chen, Kun Yan, Yin Dai,

More information

Surveillance for Hepatocellular Carcinoma

Surveillance for Hepatocellular Carcinoma Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April

More information

Evaluation of Liver Mass Lesions. American College of Gastroenterology 2013 Regional Postgraduate Course

Evaluation of Liver Mass Lesions. American College of Gastroenterology 2013 Regional Postgraduate Course Evaluation of Liver Mass Lesions American College of Gastroenterology 2013 Regional Postgraduate Course Lewis R. Roberts, MB ChB, PhD Division of Gastroenterology and Hepatology Mayo Clinic College of

More information

Liver Cancer And Tumours

Liver Cancer And Tumours Liver Cancer And Tumours What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood from all parts of the body, cancer cells from elsewhere can

More information

Case Report pissn J Korean Soc Radiol 2012;67(4): INTRODUCTION CASE REPORT

Case Report pissn J Korean Soc Radiol 2012;67(4): INTRODUCTION CASE REPORT Case Report pissn 1738-2637 Focal Fat Deposition Developed in the Segment IV of the Liver Following Gastrectomy Mimicking a Hepatic Metastasis: Two Case Reports 1 위절제술후에간의제 4 분절에서발생한간전이를닮은국소지방침윤 : 두증례보고

More information

Imaging Decisions Start Here SM

Imaging Decisions Start Here SM Owing to its high resolution and wide anatomic coverage, dynamic first-pass perfusion 320-detector-row CT outperforms PET/CT for distinguishing benign from malignant lung nodules, researchers from Japan

More information

British Liver Transplant Group Pathology meeting September Leeds cases

British Liver Transplant Group Pathology meeting September Leeds cases British Liver Transplant Group Pathology meeting September 2014 Leeds cases Leeds Case 1 Male 61 years Liver transplant for HCV cirrhosis with HCC in January 2014. Now raised ALT and bilirubin,? acute

More information

Celsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging

Celsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging Celsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging Ronnie T.P. Poon, MBBS, MS, PhD Chair Professor of Hepatobiliary and Pancreatic Surgery Chief of Hepatobiliary and Pancreatic Surgery

More information

RICCARDO LENCIONI,CLOTILDE DELLA PINA, LAURA CROCETTI,DANIA CIONI. Chapter 1

RICCARDO LENCIONI,CLOTILDE DELLA PINA, LAURA CROCETTI,DANIA CIONI. Chapter 1 RICCARDO LENCIONI,CLOTILDE DELLA PINA, LAURA CROCETTI,DANIA CIONI Chapter 1 Impact of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines on the Use of Contrast

More information

Gastrointestinal Imaging Original Research

Gastrointestinal Imaging Original Research Gastrointestinal Imaging Original Research Potretzke et al. iphenotypic Primary Liver Carcinoma Gastrointestinal Imaging Original Research FOCUS ON: Theodora. Potretzke 1 enjamin R. Tan 2 Maria. Doyle

More information

Diagnosis of Gastric Cancer with MDCT Using the Water-Filling Method and Multiplanar Reconstruction: CT Histologic Correlation

Diagnosis of Gastric Cancer with MDCT Using the Water-Filling Method and Multiplanar Reconstruction: CT Histologic Correlation MDCT of Gastric Cancer Gastrointestinal Imaging Original Research Downloaded from www.ajronline.org by 46.3.198.21 on 01/21/18 from IP address 46.3.198.21. Copyright RRS. For personal use only; all rights

More information

MRI of Small Hepatocellular Carcinoma: Typical Features Are Less Frequent Below a Size Cutoff of 1.5 cm

MRI of Small Hepatocellular Carcinoma: Typical Features Are Less Frequent Below a Size Cutoff of 1.5 cm Gastrointestinal Imaging Original Research Choi et al. MRI of Small HCC Gastrointestinal Imaging Original Research Moon Hyung Choi 1 Joon-Il Choi 1 Young Joon Lee 1 Michael Yong Park 1 Sung Eun Rha 1 Chandana

More information

Multistep hepatocarcinogenesis is characterized by the following

Multistep hepatocarcinogenesis is characterized by the following Early hepatocellular carcinoma with high-grade atypia in small vaguely nodular lesions Hidenori Ojima, 1 Yohei Masugi, 1 Hanako Tsujikawa, 1 Katsura Emoto, 1 Yoko Fujii-Nishimura, 1 Mami Hatano, 1 Miho

More information

LIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly

LIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly LIVER IMAGING TIPS IN VARIOUS MODALITIES M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly Hepatocellular carcinoma is a common malignancy for which prevention, screening, diagnosis,

More information

Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis

Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis GE Healthcare Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis CT clinical case study lesion characterization Desiree Morgan, MD Vice Chair of Clinical Research Professor

More information

doi: /hepr Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version)

doi: /hepr Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version) bs_bs_banner Hepatology Research 2016; 46: 3 9 doi: 10.1111/hepr.12542 Special Report Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version) Masatoshi Kudo, Kazuomi Ueshima,

More information

Liver imaging takes a step forward with Ingenia

Liver imaging takes a step forward with Ingenia Publication for the Philips MRI Community ISSUE 49 2013 / 2 Liver imaging takes a step forward with Ingenia Lyon South Hospital strives to move from several studies first CT, then MR or PET to using just

More information

Pathological Classification of Hepatocellular Carcinoma

Pathological Classification of Hepatocellular Carcinoma 3 rd APASL Single Topic Conference: HCC in 3D Pathological Classification of Hepatocellular Carcinoma Glenda Lyn Y. Pua, M.D. HCC Primary liver cancer is the 2 nd most common cancer in Asia HCC is the

More information

Qiang ZHANG Qi-bao SHI Zhao-xin LIU Ming-min ZHANG. Clin Oncol Cancer Res (2010) 7: DOI /s

Qiang ZHANG Qi-bao SHI Zhao-xin LIU Ming-min ZHANG. Clin Oncol Cancer Res (2010) 7: DOI /s DOI 10.1007/s11805-010-0546-4 365 A Controlled Study on Comparing Differences in CT Perfusion Imaging between s inoculated with VX2 Lung Tumor and Patients with Squamous Cell Carcinoma of the Lung Qiang

More information

HCC e CEUS. Prof. A. Giorgio. Direttore IX UOC di Malattie Infettive ad Indirizzo Ecointerventistico

HCC e CEUS. Prof. A. Giorgio. Direttore IX UOC di Malattie Infettive ad Indirizzo Ecointerventistico HCC e CEUS Prof. A. Giorgio Direttore IX UOC di Malattie Infettive ad Indirizzo Ecointerventistico The natural history of compensated cirrhosis due to hepatitis C virus: a 17 year cohort study of 214 patients

More information

HEPATOCYTE SPECIFIC CONTRAST MEDIA: WHERE DO WE STAND?

HEPATOCYTE SPECIFIC CONTRAST MEDIA: WHERE DO WE STAND? HEPATOCYTE SPECIFIC CONTRAST MEDIA: WHERE DO WE STAND? Andrew T. Trout, MD @AndrewTroutMD Disclosures No relevant disclosures Outline Review of hepatocyte specific contrast media Review of hepatocellular

More information

Gastrointestinal Imaging Original Research

Gastrointestinal Imaging Original Research Gastrointestinal Imaging Original Research Jang et al. Multiphase CT in HCC Gastrointestinal Imaging Original Research Hyun-Jung Jang 1 Tae Kyoung Kim 1 Korosh Khalili 1 Leyla Yazdi 1 Ravi Menezes 1 Seong

More information

Focal Nodular Hyperplasia Like Nodules in Alcoholic Liver Cirrhosis: Radiologic Pathologic Correlation

Focal Nodular Hyperplasia Like Nodules in Alcoholic Liver Cirrhosis: Radiologic Pathologic Correlation Lee et al. Nodules in lcoholic Liver irrhosis Hepatobiliary Imaging linical Observations Young Han Lee 1 Seong Hyun Kim 1,2 Mee-Yon ho 3 Kwang Yong Shim 4 Myung Soon Kim 1 Lee YH, Kim SH, ho MY, Shim KY,

More information

Dual Energy CT of the Liver

Dual Energy CT of the Liver 34th Annual Course October 2011 Washington, DC Dual Energy CT of the Liver Vassilios Raptopoulos, MD Beth Israel Deaconess Medical Center Harvard Medical School Dual Energy CT (DECT) Different materials

More information

Liver resection for HCC

Liver resection for HCC 8 th LIVER INTEREST GROUP Annual Meeting Cape Town 2017 Liver resection for HCC Jose Ramos University of the Witwatersrand Donald Gordon Medical Centre The liver is almost unique in that treatment of the

More information

Abstract. Introduction. Patients and Methods

Abstract. Introduction. Patients and Methods The Evaluation of Hepatocellular Carcinoma with Biphasic Contrast enhanced Helical CT Scan J. Yaqoob, V. Bari, M. U. Usman, K. Munir, F. Mosharaf, W. Akhtar Department of Radiology, Aga Khan University

More information

Invasive Ductal Carcinoma with Fibrotic Focus: Mammographic and Sonographic Findings with Histopathologic Correlation

Invasive Ductal Carcinoma with Fibrotic Focus: Mammographic and Sonographic Findings with Histopathologic Correlation Mammograp hy and Sonography of Invasive Ductal arcinoma reast Imaging linical Observations Shara Millman Oken 1 ecilia L. Mercado 2 Lorenzo Memeo 3 Hanina Hibshoosh 3 Oken SM, Mercado L, Memeo L, Hibshoosh

More information

Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers

Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers 日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu

More information

Pathological Analysis of Small Hepatocellular Carcinoma with Poor Prognosis

Pathological Analysis of Small Hepatocellular Carcinoma with Poor Prognosis Pathological Analysis of Small Hepatocellular Carcinoma with Poor Prognosis Haeryoung Kim, M.D., Ph.D. Department of Pathology Seoul National University Bundang Hospital Small HCC Definition: HCC < 2cm

More information

How to evaluate tumor response? Yonsei University College of Medicine Kim, Beom Kyung

How to evaluate tumor response? Yonsei University College of Medicine Kim, Beom Kyung How to evaluate tumor response? Yonsei University College of Medicine Kim, Beom Kyung End points in research for solid cancers Overall survival (OS) The most ideal one, but requires long follow-up duration

More information

Anterior Spinal Artery and Artery of Adamkiewicz Detected by Using Multi-Detector Row CT

Anterior Spinal Artery and Artery of Adamkiewicz Detected by Using Multi-Detector Row CT AJNR Am J Neuroradiol 24:13 17, January 2003 Anterior Spinal Artery and Artery of Adamkiewicz Detected by Using Multi-Detector Row CT Kohsuke Kudo, Satoshi Terae, Takeshi Asano, Masaki Oka, Kenshi Kaneko,

More information

Malignant Focal Liver Lesions

Malignant Focal Liver Lesions Malignant Focal Liver Lesions Other Than HCC Pablo R. Ros, MD, MPH, PhD Departments of Radiology and Pathology University Hospitals Cleveland Medical Center Case Western Reserve University Pablo.Ros@UHhospitals.org

More information

Differentiating small arterial only enhancing hepatocellular carcinoma from nontumorous arteroportal shunt with an emphasis on the precontrast phase

Differentiating small arterial only enhancing hepatocellular carcinoma from nontumorous arteroportal shunt with an emphasis on the precontrast phase Differentiating small arterial only enhancing hepatocellular carcinoma from nontumorous arteroportal shunt with an emphasis on the precontrast phase Poster No.: C-0739 Congress: ECR 2015 Type: Scientific

More information

Interventional Radiology in Liver Cancer. Nakarin Inmutto MD

Interventional Radiology in Liver Cancer. Nakarin Inmutto MD Interventional Radiology in Liver Cancer Nakarin Inmutto MD Liver cancer Primary liver cancer Hepatocellular carcinoma Cholangiocarcinoma Metastasis Interventional Radiologist Diagnosis Imaging US / CT

More information

Alpha-Fetoprotein-L3 for Detection of Hepatocellular (Liver) Cancer. Original Policy Date

Alpha-Fetoprotein-L3 for Detection of Hepatocellular (Liver) Cancer. Original Policy Date MP 2.04.35 Alpha-Fetoprotein-L3 for Detection of Hepatocellular (Liver) Cancer Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature

More information

8/3/2016. Consultant for / research support from: Astellas Bayer Bracco GE Healthcare Guerbet Medrad Siemens Healthcare. Single Energy.

8/3/2016. Consultant for / research support from: Astellas Bayer Bracco GE Healthcare Guerbet Medrad Siemens Healthcare. Single Energy. U. Joseph Schoepf, MD Prof. (h.c.), FAHA, FSCBT-MR, FNASCI, FSCCT Professor of Radiology, Medicine, and Pediatrics Director, Division of Cardiovascular Imaging Consultant for / research support from: Astellas

More information

Hepatocellular Carcinoma: Diagnosis and Management

Hepatocellular Carcinoma: Diagnosis and Management Hepatocellular Carcinoma: Diagnosis and Management Nizar A. Mukhtar, MD Co-director, SMC Liver Tumor Board April 30, 2016 1 Objectives Review screening/surveillance guidelines Discuss diagnostic algorithm

More information

Pitfalls in the diagnosis of well-differentiated hepatocellular lesions

Pitfalls in the diagnosis of well-differentiated hepatocellular lesions 2013 Colorado Society of Pathology Pitfalls in the diagnosis of well-differentiated hepatocellular lesions Sanjay Kakar, MD University of California, San Francisco Outline Hepatocellular adenoma: new WHO

More information

MRI for HCC surveillance and reporting: LI-RADS. Donald G. Mitchell, M.D. Thomas Jefferson University Philadelphia, PA

MRI for HCC surveillance and reporting: LI-RADS. Donald G. Mitchell, M.D. Thomas Jefferson University Philadelphia, PA MRI for HCC surveillance and reporting: LI-RADS Donald G. Mitchell, M.D. Thomas Jefferson University Philadelphia, PA Cirrhotic Nodules Regenerative Nodule Atypical Nodule Hyperplastic Nodule Dysplastic

More information

General summary GENERAL SUMMARY

General summary GENERAL SUMMARY General summary GENERAL SUMMARY In Chapter 2.1 the long-term results and prognostic factors of radiofrequency ablation (RFA) for unresectable colorectal liver metastases (CRLM) in a single center with

More information

Radiological Reasoning: Incidentally Discovered Liver Mass

Radiological Reasoning: Incidentally Discovered Liver Mass AJR Integrative Imaging LIFELONG LEARNING FOR RADIOLOGY This Radiological Reasoning article is available for SAM credit and CME credits when completed with the additional educational material provided

More information

Sparing of Fatty Infiltration Around Focal Hepatic Lesions in Patients with Hepatic Steatosis: Sonographic Appearance with CT and MRI Correlation

Sparing of Fatty Infiltration Around Focal Hepatic Lesions in Patients with Hepatic Steatosis: Sonographic Appearance with CT and MRI Correlation Hepatobiliary Imaging Pictorial Essay Kim et al. Sonography of Hepatic Steatosis Hepatobiliary Imaging Pictorial Essay Kyoung Won Kim 1 Min Ju Kim 2 Seung Soo Lee 1 Hyoung Jung Kim 3 Yong Moon Shin 1 Pyo-Nyun

More information

The Role of Tumor Vascularity in Predicting Survival after Yttrium-90 Radioembolization for Liver Metastases

The Role of Tumor Vascularity in Predicting Survival after Yttrium-90 Radioembolization for Liver Metastases The Role of Tumor Vascularity in Predicting Survival after Yttrium-90 Radioembolization for Liver Metastases Kent T. Sato, MD, Reed A. Omary, MD, Christopher Takehana, MD, Saad Ibrahim, MD, Robert J. Lewandowski,

More information

Nonfunctioning Islet Cell Tumors of the Pancreas: Computed Tomography Findings

Nonfunctioning Islet Cell Tumors of the Pancreas: Computed Tomography Findings Chin J Radiol 2002; 27: 239-243 239 Nonfunctioning Islet Cell Tumors of the Pancreas: Computed Tomography Findings CHAO-HSUAN YEN 1 JEN-HWEY CHIANG 1 JEN-I HUANG 3 CHENG-SHI SU 2 YI-YOU CHIOU 1 CHENG-YEN

More information

Wenxin Xu, Harvard Medical School Year III. Gillian Lieberman, MD

Wenxin Xu, Harvard Medical School Year III. Gillian Lieberman, MD August 2011 Wenxin Xu, Harvard Medical School Year III Primary liver tumor, typically in setting of chronic liver disease Viral hepatitis (HBV, HCV) in 80% of cases 2nd leading cause of cancer death worldwide

More information

PET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET

PET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET Positron Emission Tomography (PET) When calling Anthem (1-800-533-1120) or using the Point of Care authorization system for a Health Service Review, the following clinical information may be needed to

More information

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital Newcastle HPB MDM updated radiology imaging protocol recommendations Author Dr John Scott. Consultant Radiologist Freeman Hospital This document is intended as a guide to aid radiologists and clinicians

More information

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management. Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician

More information

Magnetic resonance imaging findings of hepatocellular carcinoma: typical and atypical findings

Magnetic resonance imaging findings of hepatocellular carcinoma: typical and atypical findings Asian Biomedicine Vol. 4 No. 1 February 2010; 113-124 Clinical report Magnetic resonance imaging findings of hepatocellular carcinoma: typical and atypical findings Laddawan Vajragupta, Khanitha Kittisatra,

More information

Original Article. Spontaneous Healing of Breast Cancer

Original Article. Spontaneous Healing of Breast Cancer Breast Cancer Vol. 12 No. 2 April 2005 Original Article Rie Horii 1, 3, Futoshi Akiyama 1, Fujio Kasumi 2, Morio Koike 3, and Goi Sakamoto 1 1 Department of Breast Pathology, the Cancer Institute of the

More information

Effective Health Care Program

Effective Health Care Program Comparative Effectiveness Review Number 143 Effective Health Care Program Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma Executive Background and Objectives Hepatocellular carcinoma

More information

Primary Hepatic Undifferentiated Pleomorphic Sarcoma: CT and angiographic findings in two cases

Primary Hepatic Undifferentiated Pleomorphic Sarcoma: CT and angiographic findings in two cases J Radiol Sci 2013; 38: 15-19 Primary Hepatic Undifferentiated Pleomorphic Sarcoma: CT and angiographic findings in two cases Jan-Wen Ku Ying-Chi Tseng Kuo-Luon Kung Hsien-Chang Shen Yen-Lin Huang Chi-Jen

More information

Images In Gastroenterology

Images In Gastroenterology Images In Gastroenterology Thong-Ngam D, et al. THAI J GASTROENTEROL 2005 Vol. 6 No. 2 May - Aug. 2005 105 Imaging of Gastrointestinal Stromal Tumors Pornpim Fuangtharnthip, M.D. Narumol Hargroove, M.D.

More information

The Frequency and Significance of Small (15 mm) Hepatic Lesions Detected by CT

The Frequency and Significance of Small (15 mm) Hepatic Lesions Detected by CT 535 Elizabeth C. Jones1 Judith L. Chezmar Rendon C. Nelson Michael E. Bernardino Received July 22, 1991 ; accepted after revision October 16, 1991. Presented atthe annual meeting ofthe American Aoentgen

More information

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center Hepatobiliary Malignancies 206-207 Retrospective Study at Truman Medical Center Brandon Weckbaugh MD, Prarthana Patel & Sheshadri Madhusudhana MD Introduction: Hepatobiliary malignancies are cancers which

More information

CT Angiography for Delineation of Celiac and Superior Mesenteric Artery Variants in Patients Undergoing Hepatobiliary and Pancreatic Surgery

CT Angiography for Delineation of Celiac and Superior Mesenteric Artery Variants in Patients Undergoing Hepatobiliary and Pancreatic Surgery CT of Celiac rtery and SM Variants Hepatobiliary Imaging Clinical Observations Corinne. Winston 1 Nancy. Lee 2 William R. Jarnagin 3 Jerrold Teitcher 1 Ronald P. DeMatteo 3 Yuman Fong 3 Leslie H. lumgart

More information

HEPATO-BILIARY IMAGING

HEPATO-BILIARY IMAGING HEPATO-BILIARY IMAGING BY MAMDOUH MAHFOUZ MD PROF.OF RADIOLOGY CAIRO UNIVERSITY mamdouh.m5@gmail.com www.ssregypt.com CT ABDOMEN Indications Patient preparation Patient position Scanogram Fasting 4-6 hours

More information

Enhancements in Hepatobiliary Imaging:

Enhancements in Hepatobiliary Imaging: Enhancements in Hepatobiliary Imaging: S. Channual 1, MD; A. Pahwa 2, MD; S. Raman 1, MD. 1 UCLA Medical Center, Department of Radiologic Sciences 2 Olive-View UCLA Medical Center, Department of Radiology

More information

Histologic characteristics of small hepatocellular carcinomas showing atypical enhancement patterns on 4-phase multidetector CT examination

Histologic characteristics of small hepatocellular carcinomas showing atypical enhancement patterns on 4-phase multidetector CT examination Histologic characteristics of small hepatocellular carcinomas showing atypical enhancement patterns on 4-phase multidetector CT examination Injoong Kim Department of Medicine The Graduate School, Yonsei

More information

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 46/Sep 22, 2014 Page 11296

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 46/Sep 22, 2014 Page 11296 CT SPECTRUM OF GIANT RETROPERITONEAL LIPOSARCOMAS WITH HISTOPATHOLOGICAL CORRELATION Shashikumar M. R 1, Rajendra Kumar N. L 2, C. P. Nanjaraj 3, Nishanth R. K 4, Vishwanath Joshi 5 HOW TO CITE THIS ARTICLE:

More information

Gastrointestinal Imaging Original Research

Gastrointestinal Imaging Original Research Gastrointestinal Imaging Original Research Chung et al. Response Evaluation in Patients With Colorectal Liver Metastases Gastrointestinal Imaging Original Research Woo-Suk Chung 1 Mi-Suk Park 1 Sang Joon

More information

Prediction of Microvascular Invasion of Hepatocellular Carcinoma: Preoperative CT and Histopathologic Correlation

Prediction of Microvascular Invasion of Hepatocellular Carcinoma: Preoperative CT and Histopathologic Correlation Gastrointestinal Imaging Original Research Gastrointestinal Imaging Original Research Chen-Te Chou 1,2 Ran-Chou Chen 2,3 Wei-Chan Lin 2,4 Chih-Jan Ko 5 Chia-Bang Chen 1 Yao-Li Chen 5,6 Chou CT, Chen RC,

More information

Imaging of Neuroendocrine Metastases

Imaging of Neuroendocrine Metastases Imaging of Neuroendocrine Metastases Aoife Kilcoyne, Shaunagh McDermott, Colin McCarthy,Manuel Patino, Dushyant Sahani, Michael Blake Abdominal Imaging Division Massachusetts General Hospital Disclosure

More information

Solitary Skull Metastasis as Initial Manifestation of Hepatocellular Carcinoma A Case Report

Solitary Skull Metastasis as Initial Manifestation of Hepatocellular Carcinoma A Case Report Solitary Skull Metastasis as Initial Manifestation of Hepatocellular Carcinoma A Case Report Ellyda MN a and Mohd Shafie A b a Department of Radiology, International Islamic University Malaysia, Kuantan,

More information

Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010

Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010 Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010 Self Assessment Module on Nuclear Medicine and PET/CT Case Review FDG PET/CT IN LYMPHOMA AND MELANOMA Submitted

More information

Solitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation

Solitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation 246) Prague Medical Report / Vol. 113 (2012) No. 3, p. 246 250 Solitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation Sfoungaristos S., Papatheodorou M., Kavouras

More information

Utility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography

Utility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2013;11:187 192 Utility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography YOUNG JOO JIN,*

More information

Objectives. HCC Incidence and Mortality. Disclosure Statement HCC. Imaging of Hepatocellular Carcinoma. Treatment of Hepatocellular Carcinoma

Objectives. HCC Incidence and Mortality. Disclosure Statement HCC. Imaging of Hepatocellular Carcinoma. Treatment of Hepatocellular Carcinoma Imaging of Hepatocellular Carcinoma and the use of LI RADS Treatment of Hepatocellular Carcinoma Aaron D. Anderson, D.O. AOCR April 2015 Objectives Show how the use of LI RADS can simplify the diagnosis

More information

Paul Martin MD FACG. University of Miami

Paul Martin MD FACG. University of Miami Paul Martin MD FACG University of Miami 1 Liver cirrhosis of any cause Chronic C o c hepatitis epat t s B Risk increases with Male gender Age Diabetes Smoking ~5% increase in HCV-related HCC between 1991-28

More information

Serological and histological indices of hepatocellular carcinoma and tumor volume doubling time

Serological and histological indices of hepatocellular carcinoma and tumor volume doubling time MOLECULAR AND CLINICAL ONCOLOGY 1: 977-981, 2013 Serological and histological indices of hepatocellular carcinoma and tumor volume doubling time NAOKI SHINGAKI, HIDEYUKI TAMAI, YOSHIYUKI MORI, KOSAKU MORIBATA,

More information

Jesse Civan, M.D. Medical Director, Jefferson Liver Tumor Center

Jesse Civan, M.D. Medical Director, Jefferson Liver Tumor Center Liver Tumors Jesse Civan, M.D. Medical Director, Jefferson Liver Tumor Center Differential Diagnosis Malignant Metastatic from non-hepatic primary Hepatocellular carcinoma Cholangiocarcinoma Biliary cystcarcinoma

More information

Interesting case. Vikas Kundra, M.D., Ph.D. October Vikas Kundra, M.D., Ph.D.

Interesting case. Vikas Kundra, M.D., Ph.D. October Vikas Kundra, M.D., Ph.D. Interesting case October 2012 Disclosure Information Vikas Kundra, M.D, Ph.D. I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product

More information

INTRODUCTION. Yun Ku Cho 1, Ju Won Kim 1, Mi Young Kim 1, and Hyeon Je Cho 2

INTRODUCTION. Yun Ku Cho 1, Ju Won Kim 1, Mi Young Kim 1, and Hyeon Je Cho 2 Gut and Liver, Vol. 12,. 1, January 2018, pp. 79-85 ORiginal Article n-hypervascular Hypointense dules on Hepatocyte Phase Gadoxetic Acid-Enhanced MR Images: Transformation of MR Hepatobiliary Hypointense

More information

Liver Specialty Evening Conference. Matthew M. Yeh, MD, PhD Professor of Pathology Adjunct Professor of Medicine University of Washington, Seattle

Liver Specialty Evening Conference. Matthew M. Yeh, MD, PhD Professor of Pathology Adjunct Professor of Medicine University of Washington, Seattle Liver Specialty Evening Conference Matthew M. Yeh, MD, PhD Professor of Pathology Adjunct Professor of Medicine University of Washington, Seattle Case History A 65 year-old man presents with abdominal

More information